Traxxim Biomedicines Profile
Key Indicators
- Authorised Capital ₹ 4.50 M
as on 04-12-2024
- Paid Up Capital ₹ 4.50 M
as on 04-12-2024
- Company Age 17 Year, 3 Months
- Last Filing with ROC 31 Mar 2020
- Satisfied Charges ₹ 3.32 Cr
as on 04-12-2024
About Traxxim Biomedicines
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 4.50 M and a paid-up capital of Rs 4.50 M.
The company has closed loans amounting to ₹3.32 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Yogesh Gupta and Nirupama Yogeshbhai serve as directors at the Company.
- CIN/LLPIN
U24232GJ2007PTC051746
- Company No.
051746
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Sep 2007
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Traxxim Biomedicines?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yogesh Gupta  | Additional Director | 17-Oct-2022 | Current |
| Nirupama Yogeshbhai | Director | 01-Jul-2017 | Current |
Financial Performance of Traxxim Biomedicines.
Traxxim Biomedicines Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Traxxim Biomedicines?
In 2017, Traxxim Biomedicines had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Dena Bank Creation Date: 09 Jan 2015 | ₹1.95 Cr | Satisfied |
Bank Of Baroda Creation Date: 25 Nov 2013 | ₹1.37 Cr | Satisfied |
How Many Employees Work at Traxxim Biomedicines?
Unlock and access historical data on people associated with Traxxim Biomedicines, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Traxxim Biomedicines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Traxxim Biomedicines's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
